Tyra Biosciences Inc.

8.68
-0.04 (-0.46%)
At close: Apr 02, 2025, 3:59 PM
8.80
1.39%
After-hours: Apr 02, 2025, 07:56 PM EDT

Tyra Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 353K 296K 140K 47K 8K
Gross Profit n/a -353K -296K -140K -47K -8K
Operating Income -104.18M -79.94M -58.93M -26.29M -9.3M -3.12M
Interest Income n/a 10.85M 3.65M 13K 1.00 1.00
Pretax Income -86.48M -69.13M -55.33M -26.29M -9.34M -4.07M
Net Income -86.48M -69.13M -51.72M -26.14M -9.31M -4.06M
Selling & General & Admin 24.1M 17.43M 15.92M 5.65M 2.09M 1.33M
Research & Development 80.08M 62.16M 43.01M 20.64M 7.2M 1.79M
Other Expenses n/a n/a -50K -19K -23K -8K
Operating Expenses 104.18M 79.94M 58.93M 26.29M 9.3M 3.12M
Interest Expense n/a n/a n/a n/a 1K 1K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 79.94M 58.93M 26.29M 9.3M 3.12M
Income Tax n/a n/a -3.6M -153K -22K -7K
Shares Outstanding (Basic) 57.22M 42.7M 41.88M 41.44M 42.54M 42.54M
Shares Outstanding (Diluted) 57.22M 42.7M 41.88M 41.44M 42.54M 42.54M
EPS (Basic) -1.51 -1.62 -1.23 -0.63 -0.22 -0.1
EPS (Diluted) -1.51 -1.62 -1.23 -0.63 -0.22 -0.1
EBITDA -104.18M -79.59M -58.63M -26.15M -9.25M -3.11M
EBIT n/a -79.94M -58.93M -26.29M -9.34M -3.12M
Depreciation & Amortization n/a 353K 296K 140K 47K 8K